HIV/STD Risk and PrEP Implementation Messaging Among Gay, Bisexual, and Other Men Who Have Sex with Men
Launched by EMORY UNIVERSITY · Dec 14, 2023
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how men who have sex with men (MSM) can better protect themselves from HIV and other sexually transmitted infections (STIs). Researchers want to understand factors like the use of Pre-Exposure Prophylaxis (PrEP), which is a medication that can help prevent HIV, as well as condom use and behavioral choices related to sex and substance use. The study will involve participants from Atlanta, Chicago, and San Diego, who will complete surveys every three months and undergo STI testing every six months. Participants will also take part in discussions and interviews to share their experiences.
To be eligible for this study, participants must be at least 18 years old, be assigned male at birth, identify as cis-gender males, and have had at least one male anal sex partner in the last six months. They should also have a smartphone with data service and be willing to use a health-related app during the study. This research will last for two years, and participants can expect to contribute their insights while receiving support and testing for HIV and STIs. It's a great opportunity for eligible men to engage in important research that can help improve health outcomes in their communities.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male at birth
- • Self-identify as Cis-gender Male
- • Ages 18 or older
- • ≥1 Male anal sex partner in the 6 months before the baseline screener
- • Live in or near Atlanta, Chicago, or San Diego
- • Owns cell phone with data service
- • Willing to download a health-related app to their cell phone as part of the research study
- • Willing to participate in a 2-year cohort study with quarterly surveys and HIV and mailed STI self-testing
- • Able to provide ≥ 2 means of contact
- • Not currently enrolled in another HIV prevention clinical trial
- • Not currently living with HIV
- Exclusion Criteria:
- • Female at birth
- • Do not self-identify as Cis-gender Male
- • Individuals \< 18 years of age
- • HIV positive status
- • No male anal sex partner in the 6 months before the baseline interview
- • Does not own a mobile phone with data service
- • Not willing to download a health-related app to their cell phone as part of the research study
- • Live outside the metro Atlanta Metropolitan Statistical Area and/or planning to move from the Atlanta area in the next 2 years
- • Currently enrolled in an HIV prevention or treatment clinical trial
About Emory University
Emory University, a leading research institution located in Atlanta, Georgia, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Emory harnesses the expertise of its renowned faculty and state-of-the-art facilities to conduct cutting-edge research across various fields, including oncology, neurology, and infectious diseases. The university's commitment to ethical research practices and patient safety ensures that all clinical trials are designed to generate valuable data that can lead to significant therapeutic advancements. By fostering partnerships with local hospitals and community organizations, Emory strives to translate research findings into real-world applications, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
San Diego, California, United States
Atlanta, Georgia, United States
Patients applied
Trial Officials
Patrick Sullivan, DVM
Principal Investigator
Rollins School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported